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Abstract
A 34-year-old patient was treated with constant intravenous infusion of sulprostone because of postpartum hemorrhage from 
a hypotonic uterus. The arm in which sulprostone had been infused was painful 23 h after infusion. A day later, the arm was found 
to be blueish, edematous and extremely painful as a result of arterial spasm. The vasospasm was probably caused by accidental 
subcutaneous infusion o f sulprostone as a result o f a displaced intravenous catheter. A diagnosis of critical limb ischemia was made. 
Treatment with the prostacyclin-analogue iloprost resulted in full recovery. Critical limb ischemia as a serious complication of sul­
prostone has not been previously reported.
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1. Introduction
Sulprostone is a synthetic prostaglandin E2 derivative 
that increases m uscular tone and is used for term ination 
o f pregnancy and for atonic hemorrhage. Several side- 
effects o f sulprostone have been reported, including 
common ones, such as nausea, vomiting and chills, and 
more threatening side-effects, such as bronchial spasms 
in predisposed patients, uterine rupture [1], convulsions 
in epileptic women [2] and m yocardial ischemia as a 
result o f coronary artery spasm [3]. Critical limb 
ischemia has not previously been reported as a com­
plication o f sulprostone treatm ent.
‘ Corresponding author, Tel.: +31 10 4087596; Fax: +31 10 
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2. Case report
A healthy 34-year-old, normotensive, non-smoking, 
black woman, gravida-VIII, para-II was adm itted at 33 
weeks gestation because o f vaginal blood loss. In the 
past she had two uncomplicated term  deliveries, one ec­
topic pregnancy treated with salpingotomy and four 
artificial abortions. She had recovered from hepatitis-B 
infection and had been treated for syphilis. In this preg­
nancy gestational diabetes was treated with a diet. A t 29 
weeks, a diagnosis o f  polyhydramnios was made, with 
amniotic fluid pockets o f 14 cm in diameter on u ltra­
sound examination and a norm al fetus. A t 33 weeks, 2 
days after admission for vaginal blood loss, the mem­
branes ruptured spontaneously and threatened preterm 
labor was treated with fenoterol in a dose o f  1.0 
jig-m in-1 until 34 weeks gestation. Three days later, at 
a gestational age o f 34 3/7 weeks she developed signs of
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an intra-uterine infection with fever, a painful uterus, 
fetal tachycardia and foul-smelling amniotic fluid and 
she went into spontaneous labor. Antibiotic therapy 
(amoxycilline and cefotaxime) was initiated and 2 h later 
she delivered vaginally o f a healthy female infant, 2450 
g, with Apgar scores o f 8 and 7 after 1 and 5 min, respec­
tively, and an umbilical artery pH  o f 7.22. The newborn 
infant was immunized with hepatitis-B vaccine, was 
treated with antibiotics for several days and did well. 
Following intram uscular injection o f 5 units o f  oxytocin 
and controlled cord traction, the placenta was delivered 
40 min after the infant and found complete. Blood loss 
at that time measured 700 ml and 0.2 mg 
methylergometrine i.m. was given prophylactically. The 
uterus was normally contracted. Forty minutes later, 
after a sudden hemorrhage o f 800 ml blood, the patient 
went into shock (blood pressure 70/40 mmHg, heart rate 
112 beats • m in“ 1). Volume depletion was treated with 
1.0 1 colloid solution and uterineatony was treated with 
uterine stimulants (oxytocin 10 units and 
methylergometrine 0.2 mg intravenously). The bladder 
was empty. U nder general anesthesia, the uterine cavity 
was manually checked for retained placental fragments 
and the vagina was inspected for lacerations and both 
were found absent. Curettage was performed because 
the anterior wall o f the uterus was slightly irregular, but 
virtually no m aterial was obtained. Because the atonic 
hemorrhage persisted, 500 ¡ig sulprostone was given by 
intracervical injection, followed by intravenous infusion 
of sulprostone in a dose of 125 /¿g • h -1 into the 
cephalic vein o f the left arm, and the uterus was packed 
with gauzes. After a transfusion with six units o f  packed 
cells to  substitute for a total blood loss o f 2.5 1, the pa­
tient was hemodynamically stable. The packing was 
removed after a few hours and sulprostone infusion was
Fig. 1. The angiograms of upper arm (A) and hand (B) show 
vasospasm of the brachial (1) and ulnar (2) artery, indicated by the ar­
rows. The hand is poorly perfused, predominantly by the median 
artery (3).
discontinued after 23 h. A t that time the patient com­
plained o f pain and edema o f the left hand and the infu­
sion line was removed. The next day the patient 
complained o f an increasingly painful left arm  and 
hand. On inspection the hand and forearm  were found 
to be blueish, edematous and very painful on palpation. 
Movements o f the wrist and fingers were virtually im­
possible because o f the pain. The fore-arm was cold, 
pulsations o f the radial, ulnar and brachial arteries 
could not be felt and capillary refill was poor. Doppler 
examination showed virtual absence o f blood flow in the 
radial and ulnar arteries. Selective angiography of the 
subclavian artery showed a normal axillary artery. The 
brachial artery showed m arked narrowing and the distal 
parts of the ulnar and radial artery could no t be visualiz­
ed because of strong vasospasms. The hand was poorly 
supplied predominantly by the median artery (Fig. 1). A 
thrombotic mass was not seen. A presumptive diagnosis 
o f arterial spasm, resulting from subcutaneous rather 
than intravenous infusion o f sulprostone, was made. 
The patient was treated intravenously with the 
vasodilating prostacyclin analogue iloprost in a dose of 
6 ¿tg-h-1 for 6 h per day for 4 days. During this treat­
ment the heart rate and blood pressure were monitored. 
A part from mild hypotension and a slight headache, the 
patient experienced no side-effects from iloprost treat­
ment. A bout 12 h after the initiation o f iloprost treat­
ment the color o f the skin o f the left arm  returned to 
normal, indicating that the circulation had recovered. 
Two days after the initiation of treatm ent the pain had 
virtually disappeared. W ith physiotherapy, the arm  and 
hand regained complete norm al function and on the 
twelfth day after delivery the patient was discharged in 
good condition.
3. Discussion
Sulprostone, a synthetic prostaglandin-E2 derivative, 
has a range o f  side effects which include bronchial 
spasms, uterine rupture and convulsions. Serious car­
diovascular side-effects, including acute myocardial in­
farction attributed to coronary artery spasm, are rare 
[3]. Adverse vascular sequelae in the form o f critical 
limb ischemia have not been previously reported.
Critical limb ischemia is defined as continuous 
ischemia in a limb, with pain at rest and the imminent 
prospect o f am putation. This serious condition is usual­
ly caused by atherosclerosis or rare diseases such as 
R aynaud’s and Buerger’s disease [4], Ischemia as a side- 
effect o f medication is a rare event. In our departm ent 
at the time o f treatm ent, sulprostone was routinely given 
in a dose twice of which is currently recommended for 
termination o f pregnancy [5]. Although one cannot ex­
clude a toxic effect o f the high dose o f sulprostone or of 
the methylergometrine, or a direct traum a to  the artery 
by the displaced intravenous catheter, we feel that in the
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present case critical limb ischemia developed probably 
as a result of arterial vasospasm caused simply by acci­
dental subcutaneous infusion o f sulprostone. The 
relatively high dose, the prolonged duration o f infusion, 
the measuring o f blood pressure on the infusion arm, the 
relative long biologic half-life o f sulprostone (30-45 min 
according to  the m anufacturer) and the use o f  an infu­
sion pump, which can build up a high infusion pressure, 
may all have contributed to  the damage.
Vasospasm can be treated with a vasodilating agent. 
The prostacyclin (PGI2) analogue iloprost is an im por­
tant, relatively new, drug. Iloprost dilates the arterioles 
and venules, increases the capillary density, reduces in­
creased vascular permeability o f  the microcirculation, 
inhibits platelet aggregation and prom otes fibrinolysis 
[6]. A lthough spontaneous recovery from vasospasm 
may occur w ithout medical treatm ent, persistent 
vasospasm in critical limb ischemia may end in am puta­
tion. In the present case, the use of iloprost seems to 
have been beneficial, with rapid improvement o f signs 
and symptoms to  complete recovery from  critical limb 
ischemia. However, prevention is better than treatment. 
Critical limb ischemia can be prevented by taking great 
care when sulprostone is administered intravenously.
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